Epigenomics Publishes Cutting-Edge Review from Balapal Lab
The latest review from Drs. Raj Balapal and Shivakumar Subbanna delves into cutting-edge advancements in the regulation of histone acetylation, offering insights into potential therapeutic avenues and future outlooks for neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease. The review appears in the March edition of Epigenomics and is titled, “Unlocking the epigenetic symphony: histone acetylation’s impact on neurobehavioral change in neurodegenerative disorders.”